Company / Cost of Revenue
Neogen Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$416.5M
FY2025
5-year range
$221.9M / $473.3M
FY2021-FY2025
Trend
-12.0%
vs FY2024
Sector context
#69 of 113
Health Care
What the data says
At $416M, Neogen's cost of revenue ranks #45 of 113 in the Health Care sector. Cost of Revenue has fluctuated over the past 10 years, ranging from $125M in FY2016 to $473M in FY2024.
Based on SEC 10-K filings.
$416M in FY2025 with a 5-year CAGR of +14.5%.
Improved from $460M to $416M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +23.4%
- 5-Year CAGR
- +14.5%
- 10-Year CAGR
- -
Sector benchmark
#45 of 113 in Health CareTop 39% of 113This company $416.5M Sector average $11.3B
▼
-96.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +14.5%, indicating consistent growth.
- In FY2025, cost of revenue decreased 12.0% year-over-year.
- Ranks #69 out of 113 companies in the Health Care sector.
- Peak cost of revenue was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $416.5M | -12.0% |
| FY2024 | $473.3M | +2.8% |
| FY2023 | $460.3M | +107.5% |
| FY2022 | $221.9M | -0.2% |
| FY2021 | $222.3M | +5.0% |
| FY2020 | $211.7M | +11.8% |
| FY2019 | $189.4M | +12.6% |
| FY2018 | $168.2M | +17.3% |
| FY2017 | $143.4M | +14.9% |
| FY2016 | $124.8M | +27.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026